Trial · NCT07890675
Danang Cerebral Venous Thrombosis Registry
NCT07890675, Recruiting, Da Nang Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Danang Cerebral Venous Thrombosis Registry. Trials, record NCT07890675. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07890675
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Danang Cerebral Venous Thrombosis Registry
- NCT number
- NCT07890675
- Status
- Recruiting
- Enrollment
- 110 participants, estimated
- Lead sponsor
- Da Nang Hospital
- Conditions
- Cerebral Venous Sinus Thrombosis, Stroke, Cerebral Venous Thrombosis
- Interventions
- Standard Anticoagulant Therapy
- First posted
- 2026-10-22
- Last updated
- 2026-10-26
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Favorable Functional Outcome Assessed by the Modified Rankin Scale (mRS) | At 6 months post-diagnosis | Functional status is evaluated using the modified Rankin Scale (mRS), a standardized clinical tool measuring the degree of disability or dependence in daily activities. The scale ranges from 0 (no symptoms) to 6 (death). A favorable functional outcome is defined as an mRS score of 0 to 1 (complete recovery or no significant disability despite symptoms) |
| Secondary | Venous Recanalization Rate at 6 Months | At 6 months post-diagnosis | Venous recanalization status of the occluded cerebral venous sinuses and veins will be assessed by follow-up magnetic resonance venography (MRV) or computed tomography venography (CTV) at 6 months. Recanalization is categorized into complete recanalization, partial recanalization, or no recanalization. |
| Secondary | All-Cause Mortality at 6 Months | At 6 months post-diagnosis | The proportion of patient deaths from any cause occurring within 6 months following diagnosis. |
| Secondary | Health-Related Quality of Life Assessed by the EuroQol 5-Dimension (EQ-5D-5L) Questionnaire | At 6 months post-diagnosis | Quality of life is evaluated using the EQ-5D-5L questionnaire, which assesses 5 dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has 3 or 5 response levels. In addition, the EQ Visual Analogue Scale (EQ-VAS) records the patient's self-rated health on a vertical visual analogue scale from 0 to 100, where 0 represents the worst imaginable health state and 100 represents the best imaginable health state. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07890675
GET https://conductscience.org/api/trials/v1/NCT07890675/registered